Nexstim - Research and Development

Nexstim offers targeted and effective therapies and diagnostics for challenging brain diseases and disorders. Our technology is solidly grounded in scientific and clinical research. We closely collaborate with key opinion leaders who, like us, believe noninvasive brain stimulation harnesses the brain's own healing power—neuroplasticity. Nexstim is helping patients—and their families—get back the life they feared they had lost.

All

Financial

Customers and Trade

Research and Development

Management

11-18-2020

Nexstim Plc signs a purchase agreement worth EUR 0.9 million to develop and deliver two prototype systems for a research project

10-14-2020

Nexstim Podium Webinars Demonstrate How Nexstim Systems Have Advanced the Standard of Care for Patients

10-05-2020

Nexstim Continues to Report Promising Results in Quickly Growing Number of Patients Completing SmartFocus® rTMS Treatment of Major Depressive Disorder

09-25-2020

Pilot Study for New Chronic Pain Treatment Protocol with Nexstim NBT® System Starts in Helsinki University Hospital

09-22-2020

Pilot Study for New Depression Treatment Protocol with Nexstim NBT® System Starts in Kuopio University Hospital

09-10-2020

Nexstim Pre-Surgical Mapping Technology Covered in over 100 Scientific Articles

06-08-2020

New article published on the utility of nTMS for risk stratification in 216 patients with functionally eloquent tumors

04-17-2020

Nexstim Reports Promising Clinical Outcomes of First 55 Patients Completing SmartFocus® rTMS Treatment of Major Depressive Disorder

01-16-2020

Nexstim Plc‘s Technology Licencing Discussions Ended with a Leading California Based Academic Institution

10-02-2019

Nexstim Plc in Technology Licensing Discussions with a Leading California Based Academic Institution

08-20-2019

Nexstim reports good initial results on the use of SmartFocus® technology in treatment of major depressive disorder

06-26-2019

News